See also stories tagged with Cancer
Combining genomic analyses with information about clinical outcomes is a highly promising strategy to understanding prostate cancer and its treatment. Researchers say it could change how the disease is predicted and make ...
Jun 26, 2024
0
4
Earlier this year, Northeastern University researchers unveiled a web-based artificial intelligence tool designed to diagnose prostate cancer at a faster and more accurate rate.
Jun 25, 2024
0
33
The U.S. Food and Drug Administration has approved Merck's Keytruda (pembrolizumab) plus chemotherapy as treatment for adult patients with primary advanced or recurrent endometrial carcinoma. This is the third FDA-approved ...
Jun 24, 2024
0
0
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy ...
Jun 27, 2024
0
68
A new research perspective titled "Starving cancer cells to enhance DNA damage and immunotherapy response" has been published in Oncotarget.
Jun 26, 2024
0
0
Ovarian cancer, often diagnosed at an advanced stage, presents significant treatment challenges because patients tend to develop resistance to conventional therapies quickly. Despite aggressive treatment, recurrence rates ...
Jun 26, 2024
0
0
Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in JAMA concludes that current screening guidelines could miss early-stage prostate cancer in transgender ...
Jun 26, 2024
0
8
Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition.
Jun 26, 2024
0
1
A discovery by researchers at the University of British Columbia promises to improve care for patients with endometrial cancer, the most common gynecologic malignancy.
Jun 26, 2024
0
5
Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence.
Jun 25, 2024
0
0
